Skip to main content
Fig. 1 | Cardiovascular Ultrasound

Fig. 1

From: Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors

Fig. 1

Flow diagram for patient inclusion. Initially, 81 patients with a stable CAD were enrolled in the study. Three patients were excluded in this phase, two of them did not meet the inclusion criteria, while one withdrew the informed consent before the start of the treatment. In total 78 patients were randomized to two groups, namely alirocumab or evolocumab treatment for 6 months. In each group, one patient was lost to follow up due to SARS-Cov2 infection and the other due to personal reasons. Finally, 76 patients were included in the analysis

Back to article page

Cardiovascular Ultrasound

ISSN: 1476-7120

Contact us